Mari Holm1, Michael E Msall2, Jon Skranes3, Olaf Dammann4, Elizabeth Allred5, Alan Leviton6. 1. Department of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology, N-7489 Trondheim, Norway; Department of Public Health and Community Medicine, Tufts University School of Medicine, 136 Harrison Ave., Boston, MA 02111, USA. Electronic address: mari.holm@ntnu.no. 2. Department of Pediatrics, Section of Developmental and Behavioral Pediatrics and JP Kennedy Research Center on Intellectual and Developmental Disabilities, University of Chicago Comer Children's Hospital, 5721 S. Maryland Avenue, Chicago, IL 60637, USA. Electronic address: mmsall@peds.bsd.uchicago.edu. 3. Department of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology, N-7489 Trondheim, Norway. Electronic address: jon.skranes@ntnu.no. 4. Department of Public Health and Community Medicine, Tufts University School of Medicine, 136 Harrison Ave., Boston, MA 02111, USA; Neuroepidemiology Unit, Hannover School of Medicine, Hannover, Germany. Electronic address: olaf.dammann@tufts.edu. 5. Neurology Departments, Boston Children's Hospital, and Harvard Medical School, Au-414 300 Longwood Avenue, Boston, MA 02115-5724, USA. Electronic address: lizard@hsph.harvard.edu. 6. Neurology Departments, Boston Children's Hospital, and Harvard Medical School, Au-414 300 Longwood Avenue, Boston, MA 02115-5724, USA. Electronic address: alan.leviton@childrens.harvard.edu.
Abstract
AIM: We sought to identify the antecedents and correlates of visual field deficits (VFDs) at age 2 years among infants born before the 28th week of gestation. METHODS: The visual fields of 1023 infants were assessed by confrontation at age 2 years. We compared the ante-and postnatal characteristics and exposures of the 65 infants with a VFD to their peers who did not have a VFD. We used time-oriented logistic regression risk models to assess the associations of potential antecedents and correlates with a VFD. RESULTS: In the final regression model, VFD was associated with maternal consumption of aspirin during the current pregnancy, recurring/persistent acidemia during the first 3 postnatal days, cerebral ventriculomegaly seen on neonatal ultrasound, prethreshold retinopathy of prematurity (ROP), and supplemental oxygen and ventilator dependence at 36 weeks post-menstrual age. Birth before the 27th week was also associated with increased risk, but its significance was diminished by the addition of postnatal variables. CONCLUSION: In this sample of extremely preterm born infants, antenatal as well as early and late postnatal characteristics and exposures are associated with an increased risk of having a VFD. Our study adds to our knowledge about the complex etiology of visual deficits of prematurity, and supports a multifactorial cause of these deficits.
AIM: We sought to identify the antecedents and correlates of visual field deficits (VFDs) at age 2 years among infants born before the 28th week of gestation. METHODS: The visual fields of 1023 infants were assessed by confrontation at age 2 years. We compared the ante-and postnatal characteristics and exposures of the 65 infants with a VFD to their peers who did not have a VFD. We used time-oriented logistic regression risk models to assess the associations of potential antecedents and correlates with a VFD. RESULTS: In the final regression model, VFD was associated with maternal consumption of aspirin during the current pregnancy, recurring/persistent acidemia during the first 3 postnatal days, cerebral ventriculomegaly seen on neonatal ultrasound, prethreshold retinopathy of prematurity (ROP), and supplemental oxygen and ventilator dependence at 36 weeks post-menstrual age. Birth before the 27th week was also associated with increased risk, but its significance was diminished by the addition of postnatal variables. CONCLUSION: In this sample of extremely preterm born infants, antenatal as well as early and late postnatal characteristics and exposures are associated with an increased risk of having a VFD. Our study adds to our knowledge about the complex etiology of visual deficits of prematurity, and supports a multifactorial cause of these deficits.
Authors: Jonathan L Hecht; Andrew Onderdonk; Mary Delaney; Elizabeth N Allred; Harvey J Kliman; Eduardo Zambrano; Solveig M Pflueger; Chad A Livasy; Ina Bhan; Alan Leviton Journal: Pediatr Dev Pathol Date: 2008 Jan-Feb
Authors: Matthew Laughon; Michael T O'Shea; Elizabeth N Allred; Carl Bose; Karl Kuban; Linda J Van Marter; Richard A Ehrenkranz; Alan Leviton Journal: Pediatrics Date: 2009-07-20 Impact factor: 7.124
Authors: Andrew B Onderdonk; Mary L Delaney; Andrea M DuBois; Elizabeth N Allred; Alan Leviton Journal: Am J Obstet Gynecol Date: 2008-01 Impact factor: 8.661
Authors: Karl C K Kuban; Elizabeth N Allred; Michael O'Shea; Nigel Paneth; Marcello Pagano; Alan Leviton Journal: J Pediatr Date: 2008-06-02 Impact factor: 4.406
Authors: Jonathan L Hecht; Elizabeth N Allred; Harvey J Kliman; Eduardo Zambrano; Barbara J Doss; Aliya Husain; Solveig M V Pflueger; Chung-Ho Chang; Chad A Livasy; Drucilla Roberts; Ina Bhan; Dennis W Ross; Patricia Kaman Senagore; Alan Leviton Journal: Pathology Date: 2008-06 Impact factor: 5.306
Authors: Karl Kuban; Ira Adler; Elizabeth N Allred; Daniel Batton; Steven Bezinque; Bradford W Betz; Ellen Cavenagh; Sara Durfee; Kirsten Ecklund; Kate Feinstein; Lynn Ansley Fordham; Frederick Hampf; Joseph Junewick; Robert Lorenzo; Roy McCauley; Cindy Miller; Joanna Seibert; Barbara Specter; Jacqueline Wellman; Sjirk Westra; Alan Leviton Journal: Pediatr Radiol Date: 2007-09-28
Authors: T F McElrath; J L Hecht; O Dammann; K Boggess; A Onderdonk; G Markenson; M Harper; E Delpapa; E N Allred; A Leviton Journal: Am J Epidemiol Date: 2008-08-27 Impact factor: 4.897
Authors: Alan Leviton; Elizabeth N Allred; Raina N Fichorova; Karl C K Kuban; T Michael O'Shea; Olaf Dammann Journal: Early Hum Dev Date: 2015-12-28 Impact factor: 2.079
Authors: Charles T Wood; Olivia Linthavong; Eliana M Perrin; Alan Leviton; Elizabeth N Allred; Karl C K Kuban; T Michael O'Shea Journal: Pediatrics Date: 2018-10-05 Impact factor: 7.124